Redeye updates on Raketech following the company’s Q4-results which were largely in line with our expectations. The company also saw a solid start to 2024 and with an EBITDA guidance range in line with our forecasts we have made limited changes to our estimates and leave valuation range unchanged.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases